ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 64 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $497,502 | -15.6% | 331,668 | -10.5% | 0.30% | -8.1% |
| Q2 2023 | $589,386 | +175.2% | 370,683 | +24.2% | 0.32% | +208.7% |
| Q1 2023 | $214,187 | +23.8% | 298,560 | 0.0% | 0.10% | +2.0% |
| Q4 2022 | $173,016 | -39.1% | 298,560 | 0.0% | 0.10% | -41.4% |
| Q3 2022 | $284,000 | -33.2% | 298,560 | +20.0% | 0.17% | -30.4% |
| Q2 2022 | $425,000 | – | 248,800 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,112,355 | $40,178,000 | 34.81% |
| Versant Venture Management, LLC | 7,068,233 | $69,056,636,000 | 18.94% |
| ACUTA CAPITAL PARTNERS, LLC | 1,704,500 | $16,653,000 | 8.07% |
| Soleus Capital Management, L.P. | 313,900 | $3,067,000 | 3.57% |
| Ghost Tree Capital, LLC | 1,305,500 | $12,755,000 | 3.38% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $4,690,000 | 2.97% |
| RTW INVESTMENTS, LP | 6,631,627 | $64,791,000 | 2.79% |
| VR Adviser, LLC | 994,381 | $9,715,000 | 2.63% |
| Avoro Capital Advisors LLC | 7,150,000 | $69,856,000 | 2.36% |
| RA Capital Management | 7,272,714 | $71,054,000 | 2.24% |